|
Volumn 70, Issue 2, 2007, Pages 163-170
|
Immunogenicity of infliximab: How to handle the problem?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
ANTIBODY;
ANTIHISTAMINIC AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
HYDROCORTISONE;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
METHOTREXATE;
METHYLPREDNISOLONE;
PARACETAMOL;
PROMETHAZINE;
ADVERSE DRUG REACTION;
ANTIBODY PRODUCTION;
ARTICLE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CROHN DISEASE;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
ENTERITIS;
HEALTH SURVEY;
HUMAN;
IMMUNOGENICITY;
IMMUNOSUPPRESSIVE TREATMENT;
INFUSION REACTION;
INFUSION SYSTEM;
LONG TERM CARE;
MAINTENANCE THERAPY;
MONOTHERAPY;
QUALITY OF LIFE;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES;
ANTIBODIES, MONOCLONAL;
COLITIS, ULCERATIVE;
CROHN DISEASE;
HUMANS;
IMMUNITY, CELLULAR;
PROGNOSIS;
RISK FACTORS;
|
EID: 34447519227
PISSN: 00015644
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (42)
|
References (4)
|